DANIPHARM A/S: Financial statements 2013
CVR: 12335040
Source: annual report 2013, Danish Business Authority
01/07/2012 – 30/06/2013
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 84,814,413 and a net result of DKK 232,276. The profit margin was 0.3%. Equity in the 2013 report amounted to DKK 6,435,782. The solvency ratio was 22.6%. The company had 21 employees in the financial year.
- Revenue
- DKK 84,814,413
- Gross Profit
- DKK 21,903,186
- Profit/Loss
- DKK 232,276
- Equity
- DKK 6,435,782
- Total Assets
- DKK 28,536,691
- Employees
- 21
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.